BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17018141)

  • 1. Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells.
    Alao JP; Stavropoulou AV; Lam EW; Coombes RC
    Mol Cancer; 2006 Oct; 5():40. PubMed ID: 17018141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
    Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
    Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes.
    Chen CS; Weng SC; Tseng PH; Lin HP; Chen CS
    J Biol Chem; 2005 Nov; 280(46):38879-87. PubMed ID: 16186112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
    Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
    Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis.
    Chen XL; Ren KH; He HW; Shao RG
    Cancer Biol Ther; 2008 Jul; 7(7):1073-8. PubMed ID: 18437054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High fluence low-power laser irradiation induces apoptosis via inactivation of Akt/GSK3β signaling pathway.
    Huang L; Wu S; Xing D
    J Cell Physiol; 2011 Mar; 226(3):588-601. PubMed ID: 20683916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.
    Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S
    Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway.
    Zhu H; Han B; Pan X; Qi H; Xu L
    J Clin Pharm Ther; 2012 Feb; 37(1):65-70. PubMed ID: 21410737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.
    De Sarno P; Li X; Jope RS
    Neuropharmacology; 2002 Dec; 43(7):1158-64. PubMed ID: 12504922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichostatin A improves insulin stimulated glucose utilization and insulin signaling transduction through the repression of HDAC2.
    Sun C; Zhou J
    Biochem Pharmacol; 2008 Jul; 76(1):120-7. PubMed ID: 18495085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells.
    Xu W; Yuan X; Jung YJ; Yang Y; Basso A; Rosen N; Chung EJ; Trepel J; Neckers L
    Cancer Res; 2003 Nov; 63(22):7777-84. PubMed ID: 14633703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo.
    Zhu QY; Wang Z; Ji C; Cheng L; Yang YL; Ren J; Jin YH; Wang QJ; Gu XJ; Bi ZG; Hu G; Yang Y
    Cell Death Dis; 2011 Jan; 2(1):e117. PubMed ID: 21368888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
    Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
    J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
    Joshi MB; Ivanov D; Philippova M; Erne P; Resink TJ
    FASEB J; 2007 Oct; 21(12):3083-95. PubMed ID: 17485554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells.
    Bai J; Demirjian A; Sui J; Marasco W; Callery MP
    Biochem Biophys Res Commun; 2006 Oct; 348(4):1245-53. PubMed ID: 16904634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation of lifeguard (LFG) by Akt-/LEF-1 pathway in MCF-7 and MDA-MB 231 human breast cancer cells.
    Bucan V; Adili MY; Choi CY; Eddy MT; Vogt PM; Reimers K
    Apoptosis; 2010 Jul; 15(7):814-21. PubMed ID: 20336373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.